Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
Cyanotech Corporation (CYAN)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/13/2025: CYAN (1-star) is a SELL. SELL since 5 days. Profits (-21.43%). Updated daily EoD!
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
0 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
Analysis of Past Performance
Type Stock | Historic Profit -26.81% | Avg. Invested days 28 | Today’s Advisory SELL |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/13/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 2.53M USD | Price to earnings Ratio - | 1Y Target Price 14 |
Price to earnings Ratio - | 1Y Target Price 14 | ||
Volume (30-day avg) - | Beta -0.24 | 52 Weeks Range 0.23 - 0.89 | Updated Date 06/29/2025 |
52 Weeks Range 0.23 - 0.89 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.45 |
Earnings Date
Report Date 2025-06-20 | When - | Estimate - | Actual -0.09 |
Profitability
Profit Margin -13.23% | Operating Margin (TTM) -7.18% |
Management Effectiveness
Return on Assets (TTM) -6.16% | Return on Equity (TTM) -30.95% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 14199886 | Price to Sales(TTM) 0.1 |
Enterprise Value 14199886 | Price to Sales(TTM) 0.1 | ||
Enterprise Value to Revenue 0.59 | Enterprise Value to EBITDA 21.94 | Shares Outstanding 7232220 | Shares Floating 4836617 |
Shares Outstanding 7232220 | Shares Floating 4836617 | ||
Percent Insiders 38.34 | Percent Institutions - |
Upturn AI SWOT
Cyanotech Corporation
Company Overview
History and Background
Cyanotech Corporation was founded in 1983. It focuses on the production of high-value nutritional and health products from microalgae.
Core Business Areas
- Nutritional Supplements: Production and sale of astaxanthin (BioAstin) and spirulina (Nutrex Hawaii) as dietary supplements.
- Animal Feed: Supply of spirulina and astaxanthin for use in animal feed and aquaculture to enhance coloration and nutrition.
Leadership and Structure
Gerald R. Cysewski, Ph.D. is the CEO. The company has a typical corporate structure with departments for production, sales, marketing, and research.
Top Products and Market Share
Key Offerings
- BioAstin (Astaxanthin): Natural astaxanthin product sold as a dietary supplement. Global astaxanthin market is fragmented, with various players, with market share estimates challenging to pinpoint precisely. Competitors include Valensa International, Fuji Chemical, and Algatechnologies.
- Nutrex Hawaii Spirulina: Spirulina sold as a dietary supplement. Spirulina market is also fragmented, market share is difficult to obtain; other competitors include DIC Corporation, Earthrise Nutritionals.
Market Dynamics
Industry Overview
The nutraceuticals and dietary supplements industry is growing, driven by increasing consumer awareness of health and wellness.
Positioning
Cyanotech positions itself as a premium producer of high-quality astaxanthin and spirulina sourced from Hawaii, emphasizing its unique growing environment and quality control.
Total Addressable Market (TAM)
TAM is estimated to be in the billions USD, including the global nutraceutical, dietary supplement and animal feed markets. Cyanotech focuses on premium segments.
Upturn SWOT Analysis
Strengths
- High-quality products
- Strong brand recognition
- Unique Hawaiian growing location
- Established distribution network
Weaknesses
- Limited product diversification
- Vulnerability to algae contamination
- Reliance on single growing location
- High production costs
Opportunities
- Expanding into new markets
- Developing new products
- Increasing online sales
- Capitalizing on growing demand for natural and sustainable products
Threats
- Competition from lower-cost producers
- Fluctuations in raw material prices
- Regulatory changes
- Economic downturns
Competitors and Market Share
Key Competitors
- DSM (DSM)
- BASF (BASF.DE)
- DIC Corporation (6316.JP)
Competitive Landscape
Cyanotech differentiates itself through its Hawaiian location and focus on quality, but faces competition from larger companies with greater resources.
Growth Trajectory and Initiatives
Historical Growth: Growth has been modest in recent years.
Future Projections: Future growth depends on expanding market share and product innovation. Analyst estimates are not widely available.
Recent Initiatives: Recent initiatives include expanding online sales and introducing new product formulations.
Summary
Cyanotech is a niche player in the nutraceuticals market with a focus on high-quality astaxanthin and spirulina. While the company has a strong brand and unique growing location, it faces challenges from larger competitors and fluctuating market conditions. Future growth depends on successful product innovation and market expansion. Revenue remains relatively stable but profitability is more volatile.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- Industry Reports
- Market Research Reports
- SEC Filings (limited availability)
Disclaimers:
Financial data may be estimated due to limited public availability. Market share estimates are approximate. This analysis is for informational purposes only and not financial advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Cyanotech Corporation
Exchange NASDAQ | Headquaters Kailua-Kona, HI, United States | ||
IPO Launch date 1993-06-22 | President, CEO & Director Mr. Matthew Keith Custer | ||
Sector Consumer Defensive | Industry Packaged Foods | Full time employees 83 | Website https://www.cyanotech.com |
Full time employees 83 | Website https://www.cyanotech.com | ||
Cyanotech Corporation, an agricultural company, engages in the production of natural products derived from microalgae worldwide. The company offers BioAstin Hawaiian Astaxanthin, a natural antioxidant to enhance skin, and to support eye, joint, brain, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement to support natural energy, immune system, and cardiovascular health, as well as a source of protein, antioxidant carotenoids, and essential nutrients. It also provides contract extraction and research and development services. The company sells its products through distributors, retailers, and online channels; direct to consumers; and in bulk form to manufacturers, formulators, and distributors in the health food, cosmetic manufacturers and nutraceuticals, and dietary supplement markets. Cyanotech Corporation was incorporated in 1983 and is headquartered in Kailua-Kona, Hawaii.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.